Consequences of novel Coronavirus infection on brain health are significant, requiring frequent brain monitoring Brain diagnostics in infected patients extremely limited due to their severe physical illnesses; traditional EEG time consuming, exposes frontline workers to virus transmission risk BRSF’s sanitary … Continue reading →

Seizures have been common in hospitalized COVID-19 patients, and the death rate higher in those who experienced the seizures  Due to a shortage of PPE and limited contact, EEG accessibility was limited during the pandemic The  NeuroCap can fill the … Continue reading →

Brain Scientific (OTCQB: BRSF), a commercial-stage medical device and software company focused on neurology, was recently featured in Neoscope (a publication by Futurism) as a company that champions cutting-edge research that is shaping the future in the field of brain … Continue reading →

BRSF featured in industry publication as a company that transforms EEG testing in children, cutting procedure time from 30 to as little as 5 minutes. The need for brain diagnostics in children is on the rise, but supply and availability … Continue reading →

Brain Scientific (OTCQB: BRSF), focused on modernizing the brain diagnostic market through cutting-edge technologies, recently began a collaboration with JelikaLite in a clinical trial. The clinical trial, which has 30 participants from two New York City locations, is designed to … Continue reading →

BRSF made strides on operations front to improve lead times, quality control Company experienced revenue growth, increase in assets and R&D Brain Scientific has identified that only 30% of U.S. hospitals have equipment for routine EEGs due to cost and space … Continue reading →

First order marks a significant milestone as Veterans Affairs runs the largest integrated healthcare system in the country BRSF hopes the relationship will bring cutting-edge brain diagnostics to a nationwide network of veterans’ health care Brain Scientific (OTCQB: BRSF), a commercial-stage, neurology-focused medical device and software company, has announced the start of working … Continue reading →

Brain Scientific (OTCQB: BRSF), focused on modernizing the brain diagnostic market through cutting-edge technologies, has sought to narrow the wide access-to-neurological-care gap through portable EEGs, teleneurology, on-demand data exchange and AI predictive biomarkers. “By creating cost-efficient, disposable and portable EEGs, … Continue reading →

Brain Scientific was featured in Neoscope, a publication of Futurism, a media company concentrating on the scientific and technological advances for the future Article details e-tattoo, BRSF’s solution that can capture big data in real-time about brain activity with possible … Continue reading →

Commercial application of NeuroEEG and NeuroCap growing across ICUs, acute inpatient care and other emergency care in U.S. BRSF plans to launch devices in Canada Company expands footprint, plans patent applications in Latin America, Europe Brain Scientific (OTCQB: BRSF), a … Continue reading →